Terry Hinds

Terry Hinds, Ph.D. is an Associate Professor in the Department of Pharmacology and Nutritional Sciences at the University of Kentucky College of Medicine. He holds multiple research affiliations including the Cardiovascular Research Priority Area, Center for Computational Sciences, Diabetes & Obesity Research Priority Area, Markey Cancer Center/Cancer Research Priority Initiative, Molecular and Cellular Oncology Research Program, and Substance Use Priority Research Area.

Dr. Hinds earned his Doctor of Philosophy from the University of Toledo in 2010 and his Bachelor of Science from Shawnee State University in Portsmouth, Ohio in 2002. His research focuses on bilirubin metabolism, PPAR signaling, glucocorticoid receptor pathways, and their roles in metabolic disorders, liver fibrosis, and insulin resistance.

Analysis of Dr. Hinds' recent publications reveals a strong emphasis on the hormonal functions of bilirubin, particularly its role in metabolic dysfunction-associated steatotic liver disease, insulin resistance, and cardiovascular-kidney-metabolic syndrome. His work integrates molecular biology, metabolism, and endocrinology to understand fundamental mechanisms of metabolic regulation.

Dr. Hinds has secured multiple significant research grants, primarily from the National Institutes of Health (NHLBI, NIDA, NIEHS) and the American Heart Association, focusing on metabolic disorders, liver disease, and substance use. He actively mentors students including Genesee Martinez, Evelyn Bates, and Kipp on projects related to glucocorticoid receptors, PPARgamma coregulators, and bilirubin catabolism.

His research program demonstrates a consistent trajectory exploring the intersection of metabolism, liver function, and cardiovascular health, with increasing attention to substance use disorders and their metabolic consequences in recent years.